Építés alatt – nem éles oldal

Ugrás a tartalomra

Frontlight Research

Vizsgálati helyszín

UZ Leuven

Leuven, BelgiumUniversitair Ziekenhuis Leuven

651futó vizsgálat
291lezárt vizsgálat
0a helyszín által az elmúlt 60 napban megerősített vizsgálat
–nyelv nincs megadva

A helyszín még egy vizsgálatot sem erősített meg.

Futó vizsgálatok

Még nem toboroz
A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis
NCT07335562· 3. fázis· Forrás
Még nem toboroz
A study to learn how dapirolizumab pegol transfers to babies from pregnant mothers with active systemic lupus erythematosus
2025-524595-37-00· 1. fázis· Forrás
Még nem toboroz
Within-Session Repeatability of EUS-Guided Portal Pressure Gradient Measurement
NCT07877298· Forrás
Még nem toboroz
Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma
NCT07291102· 3. fázis· Forrás
Még nem toboroz
The CORE Platform Trial
NCT07892976· Forrás
Még nem toboroz
Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 Alterations
NCT07738887· 2. fázis· Forrás
Még nem toboroz
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
NCT07441408· 3. fázis· Forrás
Még nem toboroz
Safety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis
2025-523400-72-00· 2. fázis· Forrás
Még nem toboroz
Assessment of self-perceived stress and repetitive behaviors after six weeks of daily intranasal oxytocin administration versus placebo: a randomised, multicentre, parallel group pragmatic trial in 210 men and women with autism
2025-524797-42-00· 3. fázis· Forrás
Még nem toboroz
A Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis
2026-526404-71-00· 2. fázis· Forrás
Toboroz
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
NCT07781657· 2. fázis· Forrás
Még nem toboroz
A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
NCT07919405· 3. fázis· Forrás
Toboroz
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants with Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
2024-518365-10-00· 3. fázis· Forrás
Még nem toboroz
To Evaluate the Long-term Safety and Tolerability of Acoramidis in Participants With Newly Diagnosed ATTR-CM (ACT-EARLY OLE)
NCT07116473· 3. fázis· Forrás
Toboroz
A clinical trial to assess the efficacy and safety of ontunisertib compared to placebo in patients with fibrostenosing Crohn’s disease
2026-525197-19-00· 2. fázis· Forrás
Toboroz
Phase 3 Study of Azenosertib Versus Chemotherapy in Platinum-Resistant Ovarian Cancers Positive for Cyclin E1 Protein Expression
2025-524641-27-00· 3. fázis· Forrás
Toboroz
STRATHEP: AI-Driven Treatment Stratification for Advanced Hepatocellular Carcinoma
NCT07863258· Forrás
Toboroz
Phase 3 Study of Investigator Choice of Chemotherapy with or without Zoldonrasib as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma
2025-524928-21-00· 3. fázis· Forrás
Toboroz
This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization
NCT07587658· 4. fázis· Forrás
Még nem toboroz
Phase 3 Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC 6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
2025-524969-24-00· 3. fázis· Forrás
Még nem toboroz
Prospective diagnostic performance of PET/CT using the novel fibroblast imaging tracer [18F]-AlF-FAPI-74 versus power doppler ultrasound in psoriasis patients with arthralgia: early detection of psoriatic arthritis
2026-526942-29-00· 2/3. fázis· Forrás
Toboroz
Prospective Trial of [18F]AlF-FAPI-74 for PET Imaging of Fibroblast Activation Protein in Patients With Endometriosis
NCT07876648· 2. fázis· Forrás
Toboroz
Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
NCT07441200· 2. fázis· Forrás
Toboroz
ENDO-REAL: Endometriosis and Reproductive Enhancement with Letrozole
2025-524995-53-00· 4. fázis· Forrás
Toboroz
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
NCT07817875· 3. fázis· Forrás
Toboroz
Phase 3 Trial of Tarlatamab (SC vs IV) In Extensive-Stage Small Cell Lung Cancer After Platinum based First-line Chemotherapy (DeLLphi-315)
2026-525489-23-00· 3. fázis· Forrás
Toboroz
Safety and Tolerability of REGN17235 in Adult Participants With Clonal Cytopenia of Undetermined Significance and Low-Risk Myelodysplastic Syndrome With SF3B1 Mutation
NCT07753148· 1. fázis· Forrás
Toboroz
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
NCT07701941· 1/2. fázis· Forrás
Toboroz
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
NCT07623161· 3. fázis· Forrás
Még nem toboroz
Rehabilitation Through Individualized Support and Exercise
NCT07857096· Forrás
Toboroz
A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)
2025-525009-18-00· 3. fázis· Forrás
Toboroz
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
NCT07625215· 2. fázis· Forrás
Toboroz
A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping
NCT07587242· 3. fázis· Forrás
Toboroz
Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation
NCT07405671· 4. fázis· Forrás
Toboroz
A Study to Investigate Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Systemic Lupus Erythematosus
NCT07630714· 2. fázis· Forrás
Toboroz
A neuropsychobiological approach to optimize patient selection for GLP-1-based pharmacotherapy for weight management across the binge eating spectrum
2026-526016-36-00· 4. fázis· Forrás
Toboroz
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
NCT07737743· 2. fázis· Forrás
Toboroz
A clinical trial of MK-8210 in healthy participants (MK-8210-001)
2026-527022-13-00· 1. fázis· Forrás
Toboroz
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax (ABBV-453) Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
2025-525105-20-00· 1/2. fázis· Forrás
Toboroz
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
NCT07566052· 3. fázis· Forrás
Még nem toboroz
A Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's Disease-associated Sensorimotor Polyneuropathy or Sensory Polyneuropathy (SERENITY)
NCT07760818· 2. fázis· Forrás
Toboroz
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
NCT07626411· 3. fázis· Forrás
Még nem toboroz
Long-Term Extension Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon Skipping to Evaluate the Safety and Efficacy of Endosomal Escape Vehicle Phosphorodiamidate Morpholino Oligomer Platform Products (ELEVATE-LTE)
NCT07682129· 2. fázis· Forrás
Még nem toboroz
Phase II study of ezabenlimab in patients with PD-L1-positive head and neck cancer with residual disease detected by ctDNA after chemoradiotherapy
2025-523575-36-00· 2. fázis· Forrás
Toboroz
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Global Study with an Open-Label Extension to Evaluate the Efficacy and Safety of Intravenous AOC 1044 (delpacibart zotadirsen) for the Treatment of DMD with Gene Mutations Amenable to Exon 44 Skipping
2025-523087-20-00· 3. fázis· Forrás
Toboroz
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
NCT07497087· 3. fázis· Forrás
Toboroz
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
NCT07481981· 3. fázis· Forrás
Toboroz
Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)
NCT07227805· Forrás
Még nem toboroz
The HYCORE1 Trial: Hybrid Revascularization Versus Coronary Artery Bypass Grafting
NCT05504031· Forrás
Toboroz
A Phase 1 Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
2026-525234-39-00· 1. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Tüdőrák35 toboroz
Gyermekkori daganatok34 toboroz
Petefészekrák26 toboroz
Crohn-betegség24 toboroz
Vastagbélrák23 toboroz
Áttétes emlőrák19 toboroz
Colitis ulcerosa16 toboroz
Hasnyálmirigyrák15 toboroz
Gyomor- és nyelőcsőrák13 toboroz
Méhtestrák13 toboroz
Magas vérnyomás12 toboroz
Prosztatarák12 toboroz
Akut mieloid leukémia (AML)11 toboroz
Amiotrófiás laterálszklerózis (ALS)10 toboroz
Duchenne-izomdisztrófia10 toboroz
Elhízás10 toboroz
Krónikus limfoid leukémia (CLL)10 toboroz
Koszorúér-betegség9 toboroz
Parkinson-kór9 toboroz
Fej-nyaki daganatok8 toboroz
Máj- és epeúti rák8 toboroz
Melanóma8 toboroz
Mielóma multiplex8 toboroz
Alzheimer-kór7 toboroz
Hólyagrák7 toboroz
Idiopátiás tüdőfibrózis7 toboroz
Pitvarfibrilláció7 toboroz
Pulmonális artériás hipertónia7 toboroz
Rheumatoid arthritis7 toboroz
Stroke (szélütés)7 toboroz
Szívelégtelenség7 toboroz
Lupus (SLE)6 toboroz
Mielodiszplasztikus szindróma (MDS)6 toboroz
Szarkóma6 toboroz
Tripla negatív emlőrák6 toboroz
1-es típusú cukorbetegség5 toboroz
2-es típusú cukorbetegség5 toboroz
Akut limfoid leukémia (ALL)5 toboroz
Krónikus obstruktív tüdőbetegség (COPD)5 toboroz
Pikkelysömör5 toboroz
Amiloidózis4 toboroz
Glioblasztóma4 toboroz
Lewy-testes demencia4 toboroz
Méhnyakrák4 toboroz
Mieloproliferatív neopláziák4 toboroz
Myasthenia gravis4 toboroz
Neuroendokrin daganatok4 toboroz
Vesedaganat4 toboroz
Arthritis psoriatica3 toboroz
Autizmus spektrumzavar3 toboroz
Cisztás fibrózis3 toboroz
Endometriózis3 toboroz
Hodgkin-limfóma3 toboroz
Krónikus gyulladásos demielinizációs polineuropátia (CIDP)3 toboroz
Krónikus mieloid leukémia (CML)3 toboroz
Policisztás vesebetegség3 toboroz
Sjögren-szindróma3 toboroz
Spondylitis ankylopoetica (Bechterew-kór)3 toboroz
Szisztémás szklerózis (szkleroderma)3 toboroz
Diffúz nagy B-sejtes limfóma (DLBCL)2 toboroz
Epilepszia2 toboroz
Frontotemporális demencia2 toboroz
Hemofília2 toboroz
Huntington-kór2 toboroz
Krónikus vesebetegség2 toboroz
Neuroblasztóma2 toboroz
Pompe-betegség2 toboroz
Primer biliáris cholangitis (PBC)2 toboroz
Asztma1 toboroz
Csontritkulás1 toboroz
Fabry-betegség1 toboroz
Familiáris hiperkoleszterinémia1 toboroz
Follikuláris limfóma1 toboroz
HIV-fertőzés1 toboroz
Időskori makuladegeneráció1 toboroz
IgA-nefropátia1 toboroz
Sarlósejtes vérszegénység1 toboroz
Sclerosis multiplex (SM)1 toboroz
Skizofrénia1 toboroz
Spinális izomatrófia (SMA)1 toboroz
Zsírmáj (MASLD/MASH)1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

Leállították
HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast Cancer
NCT06595563· 2. fázis· Forrás
Még nem toboroz
HOVON 168:Study on epcoritamab in frail patients with diffuse large B-Cell lymphoma (DLBCL) who have not been treated before
2025-524230-25-00· 2. fázis· Forrás
Lezárult
A clinical trial of MK-1824 in healthy participants (MK-1824-001)
2026-525748-14-00· 1. fázis· Forrás
Lezárult
A study to investigate the long-term safety, tolerability and efficacy of balinatunfib in participants with Crohn’s disease or ulcerative colitis
NCT07222189· 2. fázis· Forrás
Lezárult
A Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with NSCLC
2025-522867-13-00· 2. fázis· Forrás
Lezárult
An Open-Label Extension Study for Participants with PAH Who Have Previously Participated in a Clinical Trial with PF-07868489
2025-521155-23-00· 2. fázis· Forrás
Lezárult
A Phase 1 Study of ATV-1601, in Patients with Advanced Cancer that have AKT1 E17K Mutations
2025-521480-12-00· 1. fázis· Forrás
Toboroz
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
NCT07048262· 2. fázis· Forrás
Toboroz
A Phase 2a Study of the Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
2024-520201-39-00· 2. fázis· Forrás
Lezárult
A Study With CIT-013 in RA Patients
NCT06567470· 2. fázis· Forrás
Lezárult
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
NCT06926660· 2. fázis· Forrás
Toboroz
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
NCT06699849· 2. fázis· Forrás
Lezárult
A study to investigate efficacy and safety of SAR441566 in patients with ulcerative colitis
NCT06867094· 2. fázis· Forrás
Lezárult
A Phase 2b Study to Assess the Safety and tolerability of Batoclimab in Patients with CIDP
2024-518364-12-00· 2. fázis· Forrás
Lezárult
A Study to see How Well and How Safely Different Treatments Work in a Group of Patients with Non-Small Cell Lung Cancer, Chosen Based on their Biomarker Status
2024-511239-91-00· 2. fázis· Forrás
Lezárult
A trial to learn how safe AZD0022 is, how well it works, and how it moves throughout the body over time in adults with tumors that have a KRAS-G12D mutation, when given alone and with other cancer drugs
NCT06599502· 1/2. fázis· Forrás
Lezárult
A Study of the Efficacy and Safety of Efgartigimod in Patients with Primary Sjögren's Syndrome (pSjD) (UNITY)
NCT06684847· 3. fázis· Forrás
Lezárult
A Phase 3, Open-Label, Long-Term Safety Extension Study Evaluating the Safety and Tolerability of the Fixed-Dose Combination of Obeticholic Acid and Bezafibrate in Subjects with Primary Biliary Cholangitis
2023-507771-22-01· 3. fázis· Forrás
Fut, nem toboroz
Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
NCT06840483· 2. fázis· Forrás
Fut, nem toboroz
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
NCT06744920· 3. fázis· Forrás
Lezárult
A study to find a suitable dose of BI 765883 and to test whether it helps people with advanced pancreatic cancer when taken alone or together with chemotherapy
2023-508998-85-00· 1. fázis· Forrás
Fut, nem toboroz
Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)
NCT06632951· 2. fázis· Forrás
Fut, nem toboroz
A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)
NCT06593522· 2. fázis· Forrás
Lezárult
A clinical study of MK-2420 in healthy men (MK-2420-003)
2024-518104-47-00· 1. fázis· Forrás
Lezárult
Smart MDI Study (CIP343)
NCT06645834· Forrás
Lezárult
Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)
NCT06433219· 2. fázis· Forrás
Lezárult
A safety and efficacy study of ARGX-119 in adult patients with Amyotrophic Lateral Sclerosis (ALS) (reALiSe)
NCT06441682· 2. fázis· Forrás
Fut, nem toboroz
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
NCT06321601· 3. fázis· Forrás
Visszavonták
3rd Generation Resorbable Magnesium Scaffolds vs Biodegradable Polymer Stents in NSTE/ACS
NCT06409117· Forrás
Fut, nem toboroz
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
NCT06564142· 3. fázis· Forrás
Lezárult
A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease
NCT06522997· 2. fázis· Forrás
Lezárult
A Phase 2 Dose-Finding Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Reduced Ejection Fraction
2023-508736-62-00· 2. fázis· Forrás
Fut, nem toboroz
A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
NCT06544616· 2. fázis· Forrás
Toboroz
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
NCT06282575· 3. fázis· Forrás
Toboroz
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients with Myasthenia Gravis
2023-507539-40-00· 2. fázis· Forrás
Lezárult
A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF)
2023-506185-31-00· 2/3. fázis· Forrás
Fut, nem toboroz
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
NCT06456580· 3. fázis· Forrás
Lezárult
Add-on Clioquinol in drug-resistant epilepsy: an exploratory study
2024-511388-27-04· 2. fázis· Forrás
Fut, nem toboroz
A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not Work
NCT06290128· 3. fázis· Forrás
Leállították
To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate
NCT06488911· 3. fázis· Forrás
Lezárult
Open-label Extension of Vericiguat in Pediatric Participants with Heart Failure due to Left Ventricular Systolic Dysfunction
2023-506210-40-00· 3. fázis· Forrás
Lezárult
Effects of maintenance cabozantinib+BSC versus BSC in children and AYA with osteosarcoma. ( CabOSTar )
NCT06341712· 2. fázis· Forrás
Fut, nem toboroz
Safety, Pharmacokinetics, and Preliminary Efficacy of BYON4413 in Acute Myeloid Leukemia and Myelodysplastic Neoplasms.
NCT06359002· 1. fázis· Forrás
Lezárult
Robotic Subretinal tPA Injection Study
NCT06347107· Forrás
Lezárult
A Phase 1, Open-Label Study to Investigate the TARP-ɣ8 Receptor Occupancy of RAP-219 Using a TARP-γ8 PET Tracer in Healthy Adult Participants
2024-512151-21-00· 1. fázis· Forrás
Lezárult
A study evaluating the safety and efficacy of GLPG5101 (19CP02) in subjects with non-Hodgkin lymphoma
NCT06561425· 1/2. fázis· Forrás
Lezárult
Clinical Trial to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Adults With CF
NCT06468527· 2. fázis· Forrás
Lezárult
A Phase IIb, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Subjects with Cystic Fibrosis Aged 18 Years or Older (CHOICES)
2022-500410-26-01· 2. fázis· Forrás
Toboroz
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
NCT06414954· 2. fázis· Forrás
Lezárult
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants with Moderate to Severe Ulcerative Colitis
2023-506655-19-00· 2. fázis· Forrás

Helyszínadatok: ClinicalTrials.govFrissítve: 2026. nov. 12.